Skip to content

The Health Effect of Diet Rich in Nordic Berries

The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01414647
Acronym
Berry
Enrollment
56
Registered
2011-08-11
Start date
2006-01-31
Completion date
2010-03-31
Last updated
2018-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia, Impaired Glucose Tolerance, Low-grade Inflammation, Metabolic Syndrome

Keywords

Bilberry, Vaccinium myrtillus, Metabolic syndrome, Glucose metabolism, Lipid metabolism, Inflammation, Gene expression

Brief summary

Dietary polyphenols might have beneficial effects on glucose and lipid metabolism based on the studies made in animals or cell cultures. The findings regarding the possible decrease of low-grade inflammation are existing also in humans. Low-grade inflammation has been suggested to be a mechanistic link between obesity and its consequences on cardiometabolic health. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers.

Detailed description

Berries are traditionally an important part of the Nordic diet. About 50 different berries are grown in the northern region, and about half of them are edible. Phenolic compounds are one of the most diverse group of secondary metabolites present in edible plants, and berries are especially rich in them. Flavonoids, phenolic acids, lignans and complex phenolic polymers (polymeric tannins) are typical for berries. Phenolic compounds are reported to have a variety of beneficial biological properties. They are potent antioxidants, and exhibit various other physiological activities including anti-inflammatory, antimicrobial, antiallergic, anticarcinogenic and antihypertensive activities. Epidemiological studies indicate that diet rich in phenolic compound correlates with lower risk of cancer and cardiovascular disease. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers and gene expression profile in peripheral blood mononuclear cells (PBMCs) in subjects with features of metabolic syndrome. Randomized, controlled clinical intervention including 4 wk run-in period, 8 wk dietary intervention and 4 wk recovery period was conducted.

Interventions

DIETARY_SUPPLEMENT300 g of strawberry, raspberry and cloudberry

100 g of strawberry puree, 100 g of frozen raspberries and 100 g frozen cloudberries were concumed daily for 8 weeks. Bilberry consumption was restricted.

DIETARY_SUPPLEMENT400 g of bilberry

Equivalent amount to 400 g of fresh bilberries were consumed as 40 g of dried bilberries and as 200 g of frozen bilberries. Restriction of use of strawberries, raspberries and cloudberries were set.

OTHERControl diet

Control diet, ie. habitual diet with restriction of berry consumption was consumed for eight weeks

Sponsors

VTT Technical Research Centre, Finland
CollaboratorOTHER
Marjukka Kolehmainen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* overweight (BMI 26-39 kg/m2), and two of the following: * elevated fasting plasma glucose in the absence of diabetes (5.6-6.9 mmol/l) * abnormal serum lipid concentration: fasting serum triglyceride concentration \>1.7 mmol/L, fasting serum HDL cholesterol \<1.0 mmol/L (males) or \<1.3 mmol/L (females)) * waist circumference \>102 cm (males) or \>88 cm (females) * blood pressure \>130/85 mmHg

Exclusion criteria

* chronic diseases * use of lipid lowering medication

Design outcomes

Primary

MeasureTime frameDescription
Glucose levelweek 8Fasting glucose level oral glucose tolerance status at study week 8
Cholesterol levelweek 8total, HDL and LDL cholesterol level at the study week 8
Inflammation markersweek 8Various inflammation markers were measured at the study week 8

Secondary

MeasureTime frameDescription
Markers of sterol metabolismweek 8Markers of cholesterol absorption and synthesis were measured
gene expression in PBMCsstudy week 8Global gene expression analyses in peripheral mononuclear cells (PBMC)

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026